Clinical trial
MK0476 Study in Adult Patients With Acute Asthma (0476-322)
NCT00229970 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00229970 |
|---|---|
| Title | MK0476 Study in Adult Patients With Acute Asthma (0476-322) |
| Official title | MK0476 Phase II/III Placebo Controlled Double Blind Study |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | montelukast sodium, Comparator: Placebo |
| Enrollment | 225 |
| Start date | Sep 1, 2005 |
| Primary completion | Oct 1, 2006 |
| Completion | Jun 1, 2007 |
| First posted | Sep 30, 2005 |
| Last update posted | Feb 2, 2022 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: